NEW YORK (GenomeWeb News) – The Broad Institute has obtained approval from the state of Massachusetts to start processing clinical samples under CLIA, the institute said today.

After passing inspection by the state, the Broad has completed "a critical step on the path toward establishing a Clinical Research Sequencing Platform," according to a statement from the institute, and can now perform clinical testing, including sequencing, on patient samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.